198 related articles for article (PubMed ID: 34154618)
1. Zinc transporter SLC39A13/ZIP13 facilitates the metastasis of human ovarian cancer cells via activating Src/FAK signaling pathway.
Cheng X; Wang J; Liu C; Jiang T; Yang N; Liu D; Zhao H; Xu Z
J Exp Clin Cancer Res; 2021 Jun; 40(1):199. PubMed ID: 34154618
[TBL] [Abstract][Full Text] [Related]
2. Collagen triple helix repeat containing 1 (CTHRC1) activates Integrin β3/FAK signaling and promotes metastasis in ovarian cancer.
Guo B; Yan H; Li L; Yin K; Ji F; Zhang S
J Ovarian Res; 2017 Oct; 10(1):69. PubMed ID: 29021002
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of Gli transcription factor leads to the inhibition of migration and invasion of ovarian cancer cells via integrin β4-mediated FAK signaling.
Chen Q; Xu R; Zeng C; Lu Q; Huang D; Shi C; Zhang W; Deng L; Yan R; Rao H; Gao G; Luo S
PLoS One; 2014; 9(2):e88386. PubMed ID: 24533083
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of the zinc transporter SLC39A13 (ZIP13) is responsible for the activation of CaMKII at reperfusion and leads to myocardial ischemia/reperfusion injury in mouse hearts.
Wang J; Cheng X; Zhao H; Yang Q; Xu Z
J Mol Cell Cardiol; 2021 Mar; 152():69-79. PubMed ID: 33307093
[TBL] [Abstract][Full Text] [Related]
5. p53-inducible gene 3 promotes cell migration and invasion by activating the FAK/Src pathway in lung adenocarcinoma.
Gu MM; Gao D; Yao PA; Yu L; Yang XD; Xing CG; Zhou J; Shang ZF; Li M
Cancer Sci; 2018 Dec; 109(12):3783-3793. PubMed ID: 30281878
[TBL] [Abstract][Full Text] [Related]
6. Ligand-independent activation of c-Met by fibronectin and α(5)β(1)-integrin regulates ovarian cancer invasion and metastasis.
Mitra AK; Sawada K; Tiwari P; Mui K; Gwin K; Lengyel E
Oncogene; 2011 Mar; 30(13):1566-76. PubMed ID: 21119598
[TBL] [Abstract][Full Text] [Related]
7. Along with its favorable prognostic role, CLCA2 inhibits growth and metastasis of nasopharyngeal carcinoma cells via inhibition of FAK/ERK signaling.
Qiang YY; Li CZ; Sun R; Zheng LS; Peng LX; Yang JP; Meng DF; Lang YH; Mei Y; Xie P; Xu L; Cao Y; Wei WW; Cao L; Hu H; Yang Q; Luo DH; Liang YY; Huang BJ; Qian CN
J Exp Clin Cancer Res; 2018 Feb; 37(1):34. PubMed ID: 29463274
[TBL] [Abstract][Full Text] [Related]
8. The zinc transporter SLC39A13/ZIP13 is required for connective tissue development; its involvement in BMP/TGF-beta signaling pathways.
Fukada T; Civic N; Furuichi T; Shimoda S; Mishima K; Higashiyama H; Idaira Y; Asada Y; Kitamura H; Yamasaki S; Hojyo S; Nakayama M; Ohara O; Koseki H; Dos Santos HG; Bonafe L; Ha-Vinh R; Zankl A; Unger S; Kraenzlin ME; Beckmann JS; Saito I; Rivolta C; Ikegawa S; Superti-Furga A; Hirano T
PLoS One; 2008; 3(11):e3642. PubMed ID: 18985159
[TBL] [Abstract][Full Text] [Related]
9. LIM domain-containing 2 (LIMD2) promotes the progress of ovarian cancer via the focal adhesion signaling pathway.
Chen L; Qian J; You Q; Ma J
Bioengineered; 2021 Dec; 12(2):10089-10100. PubMed ID: 34724866
[TBL] [Abstract][Full Text] [Related]
10. Lysyl oxidase-like 4 (LOXL4) promotes proliferation and metastasis of gastric cancer via FAK/Src pathway.
Li RK; Zhao WY; Fang F; Zhuang C; Zhang XX; Yang XM; Jiang SH; Kong FZ; Tu L; Zhang WM; Yang SL; Cao H; Zhang ZG
J Cancer Res Clin Oncol; 2015 Feb; 141(2):269-81. PubMed ID: 25216702
[TBL] [Abstract][Full Text] [Related]
11. Biochemical characterization of human ZIP13 protein: a homo-dimerized zinc transporter involved in the spondylocheiro dysplastic Ehlers-Danlos syndrome.
Bin BH; Fukada T; Hosaka T; Yamasaki S; Ohashi W; Hojyo S; Miyai T; Nishida K; Yokoyama S; Hirano T
J Biol Chem; 2011 Nov; 286(46):40255-65. PubMed ID: 21917916
[TBL] [Abstract][Full Text] [Related]
12. Differential effect of the focal adhesion kinase Y397F mutant on v-Src-stimulated cell invasion and tumor growth.
Chang LC; Huang CH; Cheng CH; Chen BH; Chen HC
J Biomed Sci; 2005; 12(4):571-85. PubMed ID: 16132110
[TBL] [Abstract][Full Text] [Related]
13. Lysyl oxidase enzymatic function increases stiffness to drive colorectal cancer progression through FAK.
Baker AM; Bird D; Lang G; Cox TR; Erler JT
Oncogene; 2013 Apr; 32(14):1863-8. PubMed ID: 22641216
[TBL] [Abstract][Full Text] [Related]
14. Lidocaine inhibits the metastatic potential of ovarian cancer by blocking Na
Liu C; Yu M; Li Y; Wang H; Xu C; Zhang X; Li M; Guo H; Ma D; Guo X
Cancer Med; 2021 Jan; 10(1):337-349. PubMed ID: 33280262
[TBL] [Abstract][Full Text] [Related]
15. 1-calcium phosphate-uracil inhibits intraperitoneal metastasis by suppressing FAK in epithelial ovarian cancer.
Peng J; Yang X; Li X; Gao H; Liu N; Guo X
Cell Cycle; 2019 Aug; 18(16):1925-1937. PubMed ID: 31290719
[TBL] [Abstract][Full Text] [Related]
16. FAK Inhibition disrupts a β5 integrin signaling axis controlling anchorage-independent ovarian carcinoma growth.
Tancioni I; Uryu S; Sulzmaier FJ; Shah NR; Lawson C; Miller NL; Jean C; Chen XL; Ward KK; Schlaepfer DD
Mol Cancer Ther; 2014 Aug; 13(8):2050-61. PubMed ID: 24899686
[TBL] [Abstract][Full Text] [Related]
17. Yes-mediated phosphorylation of focal adhesion kinase at tyrosine 861 increases metastatic potential of prostate cancer cells.
Chatterji T; Varkaris AS; Parikh NU; Song JH; Cheng CJ; Schweppe RE; Alexander S; Davis JW; Troncoso P; Friedl P; Kuang J; Lin SH; Gallick GE
Oncotarget; 2015 Apr; 6(12):10175-94. PubMed ID: 25868388
[TBL] [Abstract][Full Text] [Related]
18. Frequent Loss of NISCH Promotes Tumor Proliferation and Invasion in Ovarian Cancer via Inhibiting the FAK Signal Pathway.
Li J; He X; Dong R; Wang Y; Yu J; Qiu H
Mol Cancer Ther; 2015 May; 14(5):1202-12. PubMed ID: 25724667
[TBL] [Abstract][Full Text] [Related]
19. SRPX2 promotes cell proliferation and invasion via activating FAK/SRC/ERK pathway in non-small cell lung cancer.
Li X; Liu J; Sun H; Zou Y; Chen J; Chen Y; Chen C; Wu X
Acta Biochim Pol; 2020 Jun; 67(2):165-172. PubMed ID: 32550700
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide CRISPR/Cas9 library screen identifies PCMT1 as a critical driver of ovarian cancer metastasis.
Zhang J; Li Y; Liu H; Zhang J; Wang J; Xia J; Zhang Y; Yu X; Ma J; Huang M; Wang J; Wang L; Li Q; Cui R; Yang W; Xu Y; Feng W
J Exp Clin Cancer Res; 2022 Jan; 41(1):24. PubMed ID: 35033172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
